determined that c‐type natriuretic peptide (CNP) alleviates macrophage inflammatory response in atherosclerosis.[29] Here, we presented WEE1 as a new potential target for atherosclerosis treatment through regulating macrophage inflammation. Here, WEE1 is linked to atherosclerosis.